Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Adv Biol (Weinh). 2022 Jul 1;6(10):e2200087. doi: 10.1002/adbi.202200087

Figure 2.

Figure 2.

EVs can be engineered to 1) carry bioactive cargo, and 2) express targeting proteins on the membrane surface to improve homing and cellular uptake. Engineered EVs can be delivered using multimodal biomaterial-based, clinically relevant approaches.